Literature DB >> 21727263

Clinical Reasoning: An encephalopathic 3-day-old infant.

A A Gelfand1, A Sznewajs, H C Glass, A C Jelin, E H Sherr.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21727263      PMCID： PMC3127334          DOI： 10.1212/WNL.0b013e3182231407

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

Review 1.  Valproate-induced hyperammonemic encephalopathy.

Authors:  N Segura-Bruna; A Rodriguez-Campello; V Puente; J Roquer
Journal:  Acta Neurol Scand       Date:  2006-07       Impact factor: 3.209

2.  Differentiation of transient hyperammonemia of the newborn and urea cycle enzyme defects by clinical presentation.

Authors:  M L Hudak; M D Jones; S W Brusilow
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

3.  Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

Authors:  M Msall; M L Batshaw; R Suss; S W Brusilow; E D Mellits
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

4.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Authors:  Andreas Schulze; Martin Lindner; Dirk Kohlmüller; Katharina Olgemöller; Ertan Mayatepek; Georg F Hoffmann
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

5.  Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.

Authors:  T Uchino; F Endo; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

Review 6.  Neurologic damage and neurocognitive dysfunction in urea cycle disorders.

Authors:  Gregory M Enns
Journal:  Semin Pediatr Neurol       Date:  2008-09       Impact factor: 1.636

Review 7.  Ammonia toxicity and its prevention in inherited defects of the urea cycle.

Authors:  V Walker
Journal:  Diabetes Obes Metab       Date:  2009-06-16       Impact factor: 6.577

8.  Osmotic demyelination syndrome as a consequence of treating hyperammonemia in a patient with ornithine transcarbamylase deficiency.

Authors:  Javier F Cardenas; John B Bodensteiner
Journal:  J Child Neurol       Date:  2009-02-18       Impact factor: 1.987

9.  Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.

Authors:  Gregory M Enns; Susan A Berry; Gerard T Berry; William J Rhead; Saul W Brusilow; Ada Hamosh
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

10.  Genetic approach to prenatal diagnosis in urea cycle defects.

Authors:  Johannes Häberle; Hans Georg Koch
Journal:  Prenat Diagn       Date:  2004-05       Impact factor: 3.050
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.